Turn COVID-19 Supply Chain/Manufacturing Challenges Into Opportunities

By Patti Seymour

Since the onset of the COVID-19 pandemic last year, life sciences companies have been pushed to research, develop, and manufacture COVID-19 vaccines and therapeutics at record speed. At the same time, it’s vitally important that we continue producing treatments for other diseases like cancer, diabetes, and heart disease.